Intuitive Surgical, Inc. (ISRG) Interest Coverage Ratio: N/A
The interest coverage ratio for Intuitive Surgical, Inc. (ISRG) is N/A as of Wednesday, June 10, 2026.
ISRG Interest Coverage Ratio Metrics
INTEREST COVERAGE RATIO
N/A
ISRG Competitors' Interest Coverage Ratio
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intuitive Surgical, Inc. (ISRG) | — | N/A | N/A | N/A | N/A |
| Pfizer Inc. (PFE) | $146.36B | 5.78x | 5.55x | 10.96x | 11.04x |
| Gilead Sciences, Inc. (GILD) | $151.21B | 11.43x | 6.56x | 7.26x | 7.18x |
| Abbott Laboratories (ABT) | $154.66B | 23.60x | 17.46x | 17.67x | 16.77x |
| Danaher Corporation (DHR) | $130.25B | 19.38x | 19.02x | 23.18x | 23.65x |
| CVS Health Corporation (CVS) | $125.16B | 3.33x | 3.10x | 3.72x | 4.16x |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 8.41x | 6.69x | 7.04x | 6.41x |
| Thermo Fisher Scientific Inc. (TMO) | $179.45B | 5.71x | 5.17x | 6.77x | 10.10x |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 357.95x | 357.95x | 174.48x | 123.56x |
| Amgen Inc. (AMGN) | $183.75B | 3.88x | 3.09x | 3.93x | 4.89x |
Financial Health Indicators
Interest Coverage
N/A
Debt/Equity
0.02
Current Ratio
4.87
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
- < 1.5x: EBIT is less than 1.5 times interest expense
- 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
- 3x - 5x: EBIT is between 3 and 5 times interest expense
- > 5x: EBIT is more than 5 times interest expense
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Intuitive Surgical, Inc. Interest Coverage Ratio Formula & Definition
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David J. Rosa